Thank you for your important research toward breakthroughs for people with Parkinson's and for your interest in working with The Michael J. Fox Foundation.
Below are MJFF’s open funding programs.
Find more information on our Application Guidelines here and information on proposal budgets and team composition here in English and here in LATAM Spanish.
Sign up for emails for the latest funding news. Email grants@michaeljfox.org with questions.
Browse Funding Opportunities
Open Programs
Open Programs
Programs in Review
Programs in Review
-
GP2 Underrepresented Populations PhD Program 2025
Objective:We are inviting supervisors who identify themselves as belonging to an underrepresented group in Parkinson’s disease (PD) research to apply for funding for a trainee to pursue a PhD in the genetics of PD or a related subject. Applications may be submitted with or without a potential trainee having already been identified. Overseas training (where possible) and cross-institutional collaboration with other GP2 member laboratories during the studentship is strongly recommended in order to maximize the benefit to GP2 and additional funds can be made available. -
Collaborative Research Network 2025 Technical Track Opportunity
Objective:The Aligning Science Across Parkinson’s (ASAP) Initiative invites applications from collaborative teams to join the ASAP Collaborative Research Network (CRN). For this cycle, applications within the Technical Track focused on supporting the development of novel tools that can be reliably produced and shared with the research community to accelerate validation and therapeutic R&D for emerging targets pursued or identified through ASAP discoveries will be considered. -
Collaborative Research Network 2025 Scientific Track Opportunity
Objective:The Aligning Science Across Parkinson’s (ASAP) Initiative invites applications from collaborative teams to join the ASAP Collaborative Research Network (CRN), an international, multidisciplinary, multi-institutional network of research teams working to address high-priority research questions in an effort to advance our understanding of Parkinson’s disease (PD) and drive new ideas into the R&D pipeline. For this cycle, applications within the Scientific Track that focus on dissecting the mechanisms that contribute to PD heterogeneity will be considered.
Closed Programs
Closed Programs
Additional Funding Programs and Opportunities
The Michael J. Fox Foundation operates and collaborates with many programs that offer funding or support for researchers but are not presently open for general applications. These programs welcome specialized outreach and requests.
-
ASAP’s Collaborative Research Network (CRN)
The Aligning Science Across Parkinson’s Collaborative Research Network (ASAP CRN) is an international, multidisciplinary, and multi-institutional network of collaborating investigators working to address high-priority basic science questions in Parkinson’s disease.
-
ASAP’s Global Parkinson’s Genetics Program (GP2)
The Global Parkinson’s Genetics Program (GP2) is a resource program of the Aligning Science Across Parkinson’s initiative focused on improving our understanding of the genetic architecture of Parkinson’s disease and making this knowledge globally relevant.
-
Biomarker Advancement Programs
The Michael J. Fox Foundation’s Biomarker Advancement Programs support the development of tools to biologically measure and track the progression of Parkinson’s disease (PD) from its earliest detection through more advanced stages.
-
Clinical Trial Endpoints Initiative
Through its Clinical Trial Endpoints Initiative, The Michael J. Fox Foundation supports efforts to optimize trials of Parkinson’s disease therapies.
-
Imaging Consortium
The Michael J. Fox Foundation maintains a pre-competitive consortium of industry collaborators to accelerate the development and availability of novel molecular imaging radiotracers for Parkinson's disease. The consortium supports tracer discovery, validation, and proof-of-concept studies for key Parkinson’s disease targets (such as dopamine and alpha-synuclein) and the strategic deployment of a subset of promising and validated tracers for use in multicenter clinical trials to advance therapeutics.
-
LRRK2 Investigative Therapeutics Exchange (LITE)
The LRRK2 Investigative Therapeutics Exchange (LITE) program aims to support new approaches to targeting LRRK2 with therapies, while also supporting the development of LRRK2-relevant clinical biomarkers to measure progress.
-
Parkinson’s Progression Markers Initiative (PPMI)
The Parkinson’s Progression Markers Initiative (PPMI) is a landmark study collaborating with partners around the world to create a robust open-access data set and biosample library to speed scientific breakthroughs and new treatments for Parkinson’s disease.
-
Path to Prevention (P2P)
The Path to Prevention (P2P) platform trial is designed to catalyze clinical development for prodromal Parkinson’s disease. P2P capitalizes on the infrastructure of the Parkinson’s Progression Markers Initiative (PPMI) to de-risk industry investments in pioneering therapies for individuals at risk of PD diagnosis.
-
Resources and Tools
The Michael J. Fox Foundation offers research support that goes beyond funding, including data, biospecimens and study recruitment assistance.
-
Targets to Therapies Initiative
The Targets to Therapies Initiative aims to expand the number of promising, druggable biological targets within the Parkinson’s disease translational pipeline. Leveraging The Michael J. Fox Foundation’s many years of experience supporting target validation and advancement, the initiative takes a fresh approach combining community-sourced target nomination with expert panel-guided prioritization and validation roadmaps to deliver targets that are ripe for Parkinson’s therapeutic development.
-
The Edmond J. Safra Fellowship in Movement Disorders
The Edmond J. Safra Fellowship in Movement Disorders aims to grow the global network of movement disorder specialists—neurologists with advanced training in Parkinson’s disease and other movement disorders—by supporting medical centers in training clinician-researchers who provide expert care and drive scientific progress. We accept applications from medical centers annually and prioritize expanding access in underrepresented communities.
The next round of applications opens in August 2025.
-
Grant Portal
View submitted or in progress applications.
-
Funding Alerts
Sign up for email updates on resources and initiatives to accelerate research and improve Parkinson's care.
